Editor’s note: Find the latest COVID-19 information and guidance in Medscape’s Coronavirus Resource Center.
Moderna has registered for emergency use authorization from the U.S. Food and Drug Administration to present its vaccine to adolescents aged 12-),” the company stated in a news release.
If Moderna receives authorization, it would become the next vaccine distributed to adolescents in the United States. The Pfizer/BioNTech vaccine was authorized in May for use in children aged 12-15.
“We are encouraged that the Moderna COVID-19 vaccine was highly effective at preventing COVID-19 and SARS-CoV-2 infection in adolescents,” Moderna CEO Stéphane Bancel stated in thenews launch on Thursday. “We have already filed for authorization with Health Canada and the European Medicines Agency and we will file with regulatory agencies around the world for this important younger age population.”
Moderna announced in late May that its COVID-19 vaccine was safe and seems to work in children ages 12 to 17.
The organization released early results in the clinical trial that enrolled 3,732 teens, including two-thirds who received two doses. Blood tests showed that the vaccine generated an immune response similar to that in adults.
President Joe Biden has said th